PBH moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 62 cases where PBH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on PBH as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for PBH just turned positive on October 29, 2026. Looking at past instances where PBH's MACD turned positive, the stock continued to rise in 24 of 37 cases over the following month. The odds of a continued upward trend are 65%.
The 10-day moving average for PBH crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +2.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in 167 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Aroon Indicator entered an Uptrend today. In 127 of 229 cases where PBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
PBH broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. PBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.229) is normal, around the industry mean (8.029). P/E Ratio (13.891) is within average values for comparable stocks, (-0.853). Projected Growth (PEG Ratio) (1.482) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (2.042) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
VGMS's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 91 similar instances where the Aroon Indicator showed a similar pattern. In 39 of the 91 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 43%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VGMS's RSI Indicator exited the oversold zone, 1 of 4 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 25%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on VGMS as a result. In 6 of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 30%.
The Moving Average Convergence Divergence (MACD) for VGMS just turned positive on October 08, 2026. Looking at past instances where VGMS's MACD turned positive, the stock continued to rise in 4 of 12 cases over the following month. The odds of a continued upward trend are 33%.
Following a +0.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where VGMS advanced for three days, in 32 of 89 cases, the price rose further within the following month. The odds of a continued upward trend are 36%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
VGMS moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VGMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 30%.
VGMS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
PBH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 74 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 49 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PBH | VGMS | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 25% |
| Stochastic ODDS (%) | 2 days ago 58% | 2 days ago 13% |
| Momentum ODDS (%) | 2 days ago 57% | 2 days ago 30% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 33% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 31% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 33% |
| Advances ODDS (%) | 2 days ago 52% | 13 days ago 36% |
| Declines ODDS (%) | 14 days ago 58% | 2 days ago 30% |
| BollingerBands ODDS (%) | 2 days ago 69% | 2 days ago 30% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 43% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PBH’s FA Score shows that 0 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PBH’s TA Score shows that 7 TA indicator(s) are bullish.
PBH (@Pharmaceuticals: Generic) experienced а +3.28% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.43%. For the same industry, the average monthly price growth was -7.19%, and the average quarterly price growth was +2.27%.
PBH is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PRGO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PRGO could also see price increases.
| Ticker / NAME | Correlation To PBH | 1D Price Change % | ||
|---|---|---|---|---|
| PBH | 100% | +1.37% | ||
| PRGO - PBH | 35% Loosely correlated | -0.19% | ||
| AMPH - PBH | 32% Poorly correlated | -2.49% | ||
| ANIP - PBH | 31% Poorly correlated | -1.85% | ||
| ELAN - PBH | 29% Poorly correlated | +4.51% | ||
| HLN - PBH | 29% Poorly correlated | +1.15% | ||
More | ||||
A.I.dvisor indicates that over the last year, VGMS has been loosely correlated with WS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VGMS jumps, then WS could also see price increases.
| Ticker / NAME | Correlation To VGMS | 1D Price Change % | ||
|---|---|---|---|---|
| VGMS | 100% | -0.54% | ||
| WS - VGMS | 36% Loosely correlated | +2.83% | ||
| PBH - VGMS | 17% Poorly correlated | +1.37% |